VBI Vaccines Inc reports results for the quarter ended in December - Earnings Summary

VBI Vaccines

16/04/2024 14:08

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted
loss of
1 cent​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -8 cents.  The lone analyst forecast for the quarter was
for a loss of 22 cents per share. 
    * Revenue rose 191.1% to $853.00 thousand from a year ago;
analysts expected $5.36 million. 
    * VBI Vaccines Inc's reported EPS for the quarter was a loss
of 1
cent​.
    * The company reported a quarterly loss of $156 thousand.
    * VBI Vaccines Inc shares had fallen by 3.8% this
quarter and
lost 1.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $6.00 

This summary was machine generated from LSEG data April 16 at
01:07 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.22          -0.01          Beat
 Sep. 30 2023      -0.14          -1.01          Missed
 Jun. 30 2023      -2.16          -5.05          Missed
 Mar. 31 2023      -1.25          -3.22          Missed